The British Journal of Radiology, 75 (2002), 9–16

E

2002 The British Institute of Radiology

Review article

Polycystic ovaries
1

K LAKHANI, MSc, 2A M SEIFALIAN, MSc, PhD, 3W U ATIOMO, MD, MRCOG and 3 P HARDIMAN, MD, FRCOG
1 2

Ultrasound Department, X-Ray, North Middlesex Hospital, Sterling Way, Edmonton, London N18 1QX and University Department of Surgery and 3University Department of Obstetrics and Gynaecology, Royal Free and University College Medical School, Pond Street, London NW3 2PF, UK

Abstract. Transvaginal ultrasound is currently the gold standard for diagnosing polycystic ovaries. The results of studies using ultrasound suggest a prevalence in young women of at least 20%. Between 5% and 10% of these women with polycystic ovaries shown on ultrasound will have the classical symptoms of polycystic ovary syndrome such as infertility, amenorrhoea or signs of hirsutism and obesity, as originally described by Stein and Leventhal in 1935. However, the significance of polycystic ovaries in asymptomatic women is still under investigation, as is the role of Doppler (pulsed and colour) and three-dimensional ultrasound. Ultrasound has also contributed to our understanding of the local and systemic haemodynamic changes associated with polycystic ovaries, although the relationship of these changes to morbidity and mortality is unknown. The condition now known as polycystic ovarian syndrome (PCOS) was first described by Stein and Leventhal in 1935 [1] as comprising amenorrhoea, hirsutism, obesity and sclerotic ovaries. It is one of the most common human endocrinopathies, affecting 5–10% of women of reproductive age [2]. The diagnosis of PCOS was previously based on a combination of clinical and endocrine features, including raised serum concentrations of luteinizing hormone (LH), testosterone (T) and androstenedione and reduced levels of sex hormone binding globulin [3, 4]. With the introduction of pelvic ultrasound in the 1980s, non-invasive assessment of ovarian morphology became possible. Ultrasound studies have demonstrated that approximately 20% of young women have polycystic ovaries (PCO) [5, 6], of whom around 25–70% have symptoms of infertility, menstrual irregularity or hirsutism, consistent with the diagnosis of PCOS [2, 5, 6]. However, the finding of PCO on ultrasound does not per se warrant such a diagnosis. More recently, high frequency transvaginal ultrasound (TVS) has superseded transabdominal (TA) real-time scanning in the diagnosis of PCO because of its superior resolution, whilst three-dimensional (3D) imaging and colour Doppler blood flow studies have allowed detailed evaluation of the stroma. The aim of this review article is to address the development of diagnostic ultrasound criteria of PCO with
Received 11 June 2001 and in revised form 25 September 2001, accepted 16 October 2001. The British Journal of Radiology, January 2002

successive advances in ultrasound technology and to identify its salient associations.

Developments in ultrasound imaging
With advances in technology, in particular that of TVS, ultrasound has replaced laparotomy and X-ray pelvic pneumogynaecography in the diagnosis of PCO [7, 8]. The static B-scanners of the mid 1960s allowed visualization of ovarian enlargement as well as of cysts measuring greater than 1 cm in diameter [9]. The poor resolution of the ultrasound equipment used in the early 1970s permitted visualization of the ovarian outline only, and the diagnosis of PCO was based upon increased maximum length (.4.0 cm). However, the use of a single dimension may lead to false positive results when the full bladder compresses the ovary, or false negative results when the ovaries are spherical in shape. In fact PCO tend to be more spherical in shape so that the sphericity index (expressed as ovarian width to ovarian length ratio) is greater than 0.7 in PCO. A decreased uterine width to ovarian length ratio of greater than 1.0 has also been reported in the diagnosis of PCO. All these features are now used less frequently because of their low sensitivity [10]. Thereafter, the development of grey scan equipment in the 1970s and real-time sector scanners in the 1980s improved resolution and, for the first time, cysts less than 1 cm could easily be recognized [11]. In 1981, Swanson et al [11] described PCO as enlarged and rounded, with a mean volume of 12 cm3 and containing an increased
9

A M Seifalian. of studied controls 17 25 18 24 29 29 29 29 48 48 35 0 2 40 Adams 1985 Yeh et 1987 et al [16] al [53] TA TA Pache et al 1992 [54] TV Robert et al 1995 [15] Fox et al 1999 [17] Atiomo et al 2000 [18] TV TV TV Ovarian volume No.10 . These criteria differ slightly in the number of Table 1. The most recent criteria were defined by Fox [17] and Atiomo et al [18].8 cm3 17. asymptomatic women with polycystic ovaries. these criteria have remained in widespread use even after the introduction of TVS a decade later.5 . In 1985. ovarian stroma. polycystic ovarian syndrome.10 cm3 .15 cm3 . However. of follicles 2–8 mm Increased echogenicity of OS .6 mm Mean ovarian size Increased echogenicity of OS Increased stromal area Increased maximal ovarian area Ovarian volume No.10. TA. number of small follicles (2–8 mm) encircling the ovarian cortex. and this is now accepted as the gold standard for diagnosis of PCO (Table 1).8 cm3 . of follicles 4–10 mm Ovarian volume No. PCO. of follicles 2–5 mm Increased echogenicity of OS Ovarian volume No. There have been at least four definitions of PCO using TVS. January 2002 . W U Atiomo and P Hardiman Figure 1. around an echo dense stroma. ultrasound examination route. The high resolution of the technique allows visualization of follicles less than 5 mm in diameter as well as echogenic stroma (Figure 1).5 cm3 [15].4 mm Present a a % of patients with clinical PCOS 33 72 70 74 7 About 70 About 50 About 70 94 61 55 60 46 60 Around 70 Around 80 Around 60 % of controls having the criteria 0 0 0 11 6 0 0 7 10 4 2 0 0 0 Not mentioned No. which corresponds closely to the characteristic histopathological changes (Figure 2). which required 10 or more cysts of 2–8 mm in diameter arranged peripherally Figure 2. a Total of both ovaries. Adams et al [16] published new criteria based on TA ultrasound. TV.6 cm3 .15 Present . This decrease may also reflect the broader inclusion criteria in the latter studies compared with Swanson et al who only included patients with enlarged ovaries and classic Stein–Leventhal syndrome at the extreme end of the clinical spectrum. transvaginal. Results of some ultrasound studies described in the literature Reference UER Ultrasound variable Criteria indicative of PCO . the importance of ovarian size in diagnosis has lessened as various groups [12–14] have shown a considerable overlap between PCO and normal ovaries and as the upper limit of normal has decreased from greater than 10 cm3 to 5. transabdominal. of patients studied 76 108 68 100 52 52 52 52 69 69 29 25 29 32 No. of follicles . Stained longitudinal section of a polycystic ovary showing numerous small peripheral follicles. Transvaginal image of a polycystic ovary showing peripheral distribution of follicles (arrows).8 cm3 .9 cm3 . of follicles 5–8 mm Uterine width/ovarian length Ovarian volume No. OS.11 .1 .10 Present UER. However. PCOS. 10 The British Journal of Radiology.K Lakhani.

is the presence of small follicles around an echodense ovarian stroma. there is still a degree of subjectivity in this diagnosis. In a study by KyeiMensah et al [19]. 3D ultrasound is governed by the same principles as 2D ultrasound and hence its resolution is reduced in obese women. but it may be significant that stromal blood flow in PCO (Figure 3) has been attributed to increased concentrations of serum vascular endothelial growth factor [23]. Colour Doppler allows the ovarian artery to be identified at the lateral border of the ovary as well as the ascending branch of the uterine artery at the cervicouterine junction [21]. Expertise and experience is therefore important. However. The spectral Doppler assessment of vascular changes in the ovarian and uterine arteries in women with PCO has improved The British Journal of Radiology. as numerous volume measurements of sufficient quality may be necessary to permit meaningful analysis. using colour Doppler and spectral waveform analysis we did not find any significant differences in the ovarian artery PI or RI in PCO/PCOS women compared with women with normal ovaries (unpublished data). However. Data are transferred to a computer and can be analysed later. Fox does not stipulate that the requisite numbers of follicles are seen in a single plane of the ovary. which is not seen in a normal cycling ovary. The image Doppler ultrasound Transvaginal colour and pulsed Doppler ultrasound in combination with B-mode imaging is used as a non-invasive method to assess blood flow in both obstetrics and gynaecology. subsequently the volume can be more accurately evaluated. The capillary area increases after the LH surge. The clinical significance of these changes is also under investigation and it is of interest that a higher uterine artery PI has been associated with lower conception rates during embryo transfer in in vitro fertilization [24]. our understanding of the pathogenesis of this common condition and provides an additional variable to the traditional endocrinological and more recent ultrasound features for its diagnosis. Diagnostic accuracy has evolved from increased ovarian length to the recognition of the distribution of follicles and textural changes in the ovarian stroma. measurements can be made from the image that is reconstructed and the ovarian and stromal volumes are displayed on the screen in three adjustable orthogonal planes. This technique has been used to study the haemodynamic changes in the uterine and/or ovarian arteries during the menstrual cycle in women with normal ovaries [21]. However. power Doppler does not as yet allow quantitative measurement of blood flow. 3D ultrasound has been used to measure ovarian and stromal volumes. 11 . causing an increase blood flow attributed to vasodilatation and resulting in flow detection with Doppler ultrasound [22]. there being no differences in follicular volume between normal ovaries and PCO. However. although recognition of the latter is highly subjective and depends upon equipment settings. The most consistent feature of PCO. MRI allows easier localization of the ovaries because of its multiplanar scanning of the pelvis. 3D ultrasound To avoid the difficulties in outlining or measuring ovarian size. The ultrasound diagnostic criteria of PCO have been refined with advances in technology. A typical flow velocity diagram at the stroma shows higher velocity in a 35-year-old polycystic ovary syndrome patient. 3D ultrasound has been proposed using a dedicated volumetric probe or a manual survey of the ovary [19]. January 2002 Figure 3. In clinical practice the ultrasonographer forms an impression of the ovary from the images obtained in three planes. providing information that is not available from two-dimensional (2D) ultrasound [19]. The mechanism responsible for these haemodynamic changes in PCOS is not known.Review article: Polycystic ovaries follicles and their size. Therefore. power Doppler is more sensitive to slow flow and allows the detection of blood flow within the ovarian stroma [20]. MRI Data on MRI for PCO is still limited [25]. the difference in ovarian size was accounted for by the differences in stromal volumes. Battaglia et al [20] reported a higher uterine artery pulsatility index (PI) in women with PCOS and a decreased resistance index (RI) within the ovarian stroma in PCOS (suggestive of increased downstream resistance) and a positive correlation with LH levels. From the stored data. Colour or power Doppler allows detection of the uterine and ovarian vessels as well as the network within the ovarian stroma.

and parity-matched controls but also had cystic ovaries. Although the T2 weighted sequence displays the increased number of follicles. January 2002 . The external features of PCO (increased ovarian volume. A M Seifalian. Of these women.5 T. hypothalamic anovulation and weight-related amenorrhoea. This condition is thought to arise from abnormal relaxation of the pelvic veins and may respond to progesterone therapy. irrespective of time of cycle.K Lakhani. suggesting that the stroma is highly vascularized in PCO. Figure 5). MFO resume a normal appearance following weight gain or treatment with pulsatile GnRH. although following gadolinium injection there is enhancement of the stroma. whilst PCO retain their appearance throughout reproductive life. having fewer cysts (6–10 per ovary. Pelvic pain and PCO Cystic ovaries have also been described [28] in women with venous congestion resulting in pelvic pain (Figure 6). their detection is less easy than with ultrasound because of the poor resolution of MRI. hyperprolactinaemia. In clinical practice. pregnancy or drug treatment [26]. MRI is rarely used for the diagnosis of PCO as it does not provide any more information than TVS and is also an expensive modality [25]. How PCO differ from multifollicular ovaries Multifollicular ovaries (MFO) were first described by Adams and colleagues in 1985 [16]. with no stromal hypertrophy [16]. MFO result from incomplete pulsatile gonadotrophin (GnRH) stimulation of ovarian follicular development [26]. increased roundness index (ovarian width/ ovarian length ratio) and decreased uterine width to ovarian length ratio) are easily recognized on transverse cuts. MRI of polycystic ovaries (arrows) in a 37year-old woman. Figure 4. T1 weighted sequences are less informative. unless using high magnetic fields of 1–1. 56% had cystic changes. respectively). They differ from PCO. and are encountered in mid to late normal puberty. The most useful planes are transverse and coronal and the T2 weighted sequence is best for assessing ovarian morphology as the cysts are displayed as high signal (white) and the stroma as low signal (black) (Figure 4). Furthermore. which ranged from the classic polycystic pattern to the appearance of clusters of 4–6 cysts. It may be helpful in difficult situations when ultrasound either is not possible or is unhelpful (in virgin or obese women. Transvaginal image of a multifollicular ovary. and women with MFO have normal levels of LH and T and reduced levels of follicle stimulating hormone (FSH) compared with women with PCO [27]. The British Journal of Radiology. W U Atiomo and P Hardiman quality of MRI is improved by the use of a pelvic dedicated phased array coil receiver. 12 Figure 5. Adams and co-workers [29] evaluated ovarian morphology using TA ultrasound in 55 women with chronic pelvic pain and reported that women with chronic pelvic pain due to venous congestion not only had a larger uterus and thicker endometrium compared with age. which tend to be larger (up to 10 mm in diameter) and distributed throughout the ovary Early pregnancy loss Early miscarriage has been associated with increased LH [30] and increased T [31] levels (both of which are in turn associated with PCOS).

a feature of PCO in young women. although there is evidence of biochemical abnormalities in these women similar to those present in PCOS. PCO in asymptomatic women PCO are not confined to women with the classical symptoms of the syndrome described by Stein and Leventhal [1]. However. Furthermore. histopathologists do not usually identify PCO in post-menopausal women. 38]. the prevalence of PCO was 23% [6].Review article: Polycystic ovaries resolve at the time of the menopause and thus highlight the need for long-term longitudinal data. Carmina et al [39] reported LH and androgen levels between those found in normal subjects and those found in patients with PCOS. with the advent of TVS. In a study of hospital staff volunteers using TA ultrasound. Obesity itself can lead to many changes ascribed to PCOS. The prevalence of early pregnancy loss ranges from 20–40% [32. Studies have shown a clear relationship between the raised serum LH level often found in women with PCOS and early pregnancy loss [34]. The results of this study raise the possibility that the morphological and endocrine features of PCOS may not The British Journal of Radiology. respectively [42]. In 1977. Figure 6. 33] in women with PCOS following treatment for anovulation. in a cross-sectional study of 18 post-menopausal volunteer women and 94 post-menopausal women who had undergone coronary angiography. in an observational study of 16 women with unilateral PCO and 20 women with bilateral PCO. Pelvic venous congestion in a young woman with polycystic ovary syndrome (for details see text). we found a linear trend in ultrasound and endocrine variables from controls through PCO to PCOS [40]. Moreover. however. Because of the presumed link between PCOS and early pregnancy loss in induced cycles. On the contrary. not all women with PCOS are obese. Battaglia and co-workers [42] reported that the women in the latter group had higher concentrations of androstenedione and LH to FSH ratios. One study of five women with clinical features of PCOS and cystic ovaries and five women with clinical features of PCOS and normal ovaries on TVS reported no significant endocrine differences between the two groups [41]. The relationship between ovarian morphology and symptomatology is further complicated by the assertion that some women with classical symptoms of PCOS may have normal ovaries on ultrasound. Birdsall and Farquhar [36] identified PCO in 8/18 of the volunteer group and 35/94 women in the angiography group. but to a lesser degree. This study showed that 82% of women had ultrasound appearances of PCO [33]. similar to the appearance of the polycystic and the normal ovary. 37. the clinical significance of PCO in asymptomatic women is unclear. Are PCO present in post-menopausal women? The clinical diagnosis of PCOS is conventionally restricted to pre-menopausal women. However. conversely. the women with PCO had increased serum concentrations of T. January 2002 The unilateral polycystic ovary The development of TVS has also identified a small group of women with one polycystic ovary in whom the contralateral ovary can be clearly visualized and appears normal. 13 . In 1999. thus it may be possible that obesity unmasks or even potentiates the endocrine changes of asymptomatic women with PCO to PCOS. At present. a recent study found no increase in miscarriage rate in women with polycystic ovary morphology and a history of early embryo loss compared with women with the same history but normal ovarian morphology on ultrasound [35]. Similarly. Although obesity was included in the original description of the syndrome [1]. the relationship between PCO and early miscarriage in women with spontaneous ovulatory cycles was studied in 56 women with three or more miscarriages. Three further studies have shown a prevalence of between 16% and 33% [5. grey scale and Doppler ultrasound showed different features in the affected and the unaffected ovary. in women with unilateral PCO. PCO are commonly seen in asymptomatic women.

Polycystic ovary syndrome: a changing perspective. How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin Endocrinol (Oxf) 1992. A M Seifalian. Jacobs HS. References 1. Goldhiezer JW. J Clin Endocrinol Metab 1962.1:870–2. W U Atiomo and P Hardiman Wider health implications of PCOS PCOS is common among women of reproductive age and in clinical practice these women are seen for three major reasons: infertility (74%). 6. but concerns about cardiovascular risks have not yet been clearly confirmed. but they are indicative of widespread changes in cardiovascular function in these women. Worswick L. Conclusion The ultrasound criteria for diagnosing PCO have evolved from simply increased dimensions to the recognition of a characteristic follicular pattern and textural changes in the ovarian stroma. Pelvic pneumography in the Stein and Leventhal syndrome. Lancet 1988. Honour JW. et al. Wadsworth J.31:87–120. which acts through the endothelial nitric oxide system in women with PCO. Dunaif A. non-insulin dependent diabetes mellitus (NIDDM) and the associated cardiovascular consequences. Green JA. endocrine and ultrasound features in 556 patients. Dyer S. Stein IF. 3. Conway GS. The significance of this finding in asymptomatic women is currently under investigation. In a subsequent study we reported a paradoxical constrictor response to 5% carbon dioxide (a known cerebrovasodilator) in the internal carotid artery in women with PCOS compared with women with normal ovaries [51]. Although it is not quite clear whether the estimated risk of health problems in women with PCOS actually translate into long-term morbidity and/or mortality.36:46–9. together with pulsed and colour/ power Doppler ultrasound. Evans KT. insulin resistance. Edwards EM. We are currently investigating the possibility that this represents an abnormality in endothelial function in women with PCO. menstrual irregularity (66%) and androgen excess (48%). January 2002 . but the clinical significance of these changes and the mechanisms responsible have yet to be established. as many of these women may be at an increased risk of cardiovascular disease in later life [43–45] owing to the associated risk factors of obesity. These differences were independent of blood pressure. Using risk model analysis. although only between one-quarter and one-half of these women have the classic symptoms of the syndrome. Polson DW. 3D ultrasound. Prelevic et al reported lower flow over the aortic arch [48]. Women with clinical features of the syndrome are at increased risk of developing NIDDM.30:459–70. Leventhal ML. 4. have also been used to visualize PCO. Ogden V. The reason for this discrepancy is unknown. suggestive of reduced vascular tone in the internal carotid artery in women with PCOS and PCO compared with young healthy controls. 2.K Lakhani. Clayton RN. hypertension and altered lipid profiles often observed in these women [46]. Franks S. Heterogeneity of the polycystic ovary syndrome: clinical. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Using TVS scanning and applying strict criteria. asymptomatic women with PCO must indeed have an increased likelihood of adverse health outcomes as a result of their PCO status. Am J Obstet Gynecol 1935.18:774–800. we found reduced PI and back-pressure (a better indicator of interpreting the PI in low impedance vascular beds such as the cerebral circulation [50.4fold increase in mortality. Br J Radiol 1961. 7. Rodin DA.29:181–91. The British Journal of Radiology. Interestingly. Polycystic ovaries—a common finding in normal women. Adams J.37:127–34. As clinicians it is ethical to advise 14 and suggest that women with PCO/PCOS (especially the obese ones) lose weight and adopt healthy life-style practices that could reduce their risk of developing hypertension. Clin Endocrinol (Oxf) 1989. 5.22:325–8. Clin Endocrinol (Oxf) 1989. 51]). however in the only follow-up study cardiovascular mortality was not increased [47]. Endocr Rev 1997. higher resting forearm flow during reactive hyperaemia and lower incremental forearm flow [49] in PCOS than in age-matched control women. which may influence morbidity and mortality. In a study using Doppler ultrasound. Hodgkinson J. insulin resistance and other endocrine and metabolic factors [40]. Amenorrhoea associated with bilateral polycystic ovaries. The polycystic ovary— clinical and histological features. but their clinical role is not yet established. but it has been suggested that protective mechanisms may be operative or that this cohort was in some way not representative of the general population with PCO. Franks S. Dahlgren et al [45] has estimated a 7. the prevalence of PCO in the female population is at least 20%. PCOS should no longer be considered a purely gynaecological condition. 8. The clinical significance of these changes in the cerebral circulation requires further investigation. Ultrasound is also being used to identify systemic haemodynamic changes in these women. Lees et al [52] reported a constrictor response to transdermal glyceryl trinitrate (a potent vasodilator). Haemodynamic changes have also been reported in women with PCOS.

Edwards RG. Polson DW. Internal carotid artery haemodynamics in women with polycystic ovaries. Birdsall M. Aust N Z J Obstet Gynaecol 1999. D’Ambrogio G. Fertil Steril 1997. Oxford. Bovicelli L.245: 413–21. Br J Obstet Gynaecol 1990. 38. Gilling-Smith C.172:108–13. Polycystic ovaries in pre and post-menopausal women. Biol Reprod 1990. The contribution of sonographic evaluation of ovarian size in patients with polycystic ovarian disease.51:779–86. Pearson S. Lancet 1985. Thomas-Desrousseaux P. NY: Parthenon Publishing. 2000:56–69. Stanhope R. Adams J. Campbell S.97:583–7. Transvaginal colour flow imaging of the uterine arteries during the ovarian and menstrual cycles. Abnormalities of early follicular phase LH secretion in women with recurrent early miscarriage. Alexander FM. 27. Imaging polycystic ovaries. Spencer IH. 24. Polycystic ovaries and recurrent miscarriage—a reappraisal. Franks S. Kolb BA. Swanson M. et al. Reginald PW. Cambridge: Cambridge University Press. Nakano Y. Am J Obstet Gynecol 1995.336:1141–4. Jacobs HS. editor. Dunger DB. Dewailley D. Jacobs HS. Paradisi R. Manning P. Steer CV. et al.26:977–80. Bellotti M. Br J Obstet Gynaecol 1993. Reprod Med Rev 1993. The British Journal of Radiology. Michel M. Hum Reprod 2000. Cooperberg PL. Hypersecretion of luteinizing hormone. Morphological studies of the microcirculatory system of periovulatory ovine follicles. Zaidi J. Battaglia C. Michelmore KF. Hamilton-Fairley D. Ultrasound Med Biol 2000. Transvaginal ultrasound appearances of the ovary in normal women and hirsute women with oligomenorrhoea. Purcell WM.100:1082–9.14:183–7. Salvatori M. Gaillandre L. Adams J. Purcell WM.55: 1062–8. Paulson RJ. Chang L.12: 905–9. Kawakami S. J Ultrasound Med 1985. Howels CM. Franks S. Psychological and somatic factors in women with pain due to pelvic congestion. Birdsall MA.297: 1027–8. Elli R. Reginald P. Follicular development and early luteal function of conception and non-conceptional cycles after human in-vitro fertilization: endocrine correlates. 42. Wadsworth J. Collins WP. Ovarian ultrasound assessment in normal children. UK: Blackwell Science Ltd. Hardiman P. Lakhani K.2:17–21. Polycystic ovary syndrome. Venturoli S. 33. FSH action and intraovarian regulation.15:612–5. editors. Kiddy D. 21. Backos M. Lemaitre L. Mori T. Polycystic ovary syndrome: it is always bilateral? Ultrasound Obstet Gynecol 1999. Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound.67:631–5. Medical implications of ultrasonically detected polycystic ovaries. Regan L. 5:391–5. Fossati P. Polycystic ovary disease: contribution of vaginal endosonography and reassessment of ultrasonic diagnosis. 40. 32. 1997:247–52. Fernando R. 4:341–51. Petraglia F. Polycystic ovary syndrome. Ultrasound findings in polycystic ovarian disease. 20. Brook CGD. Clin Sci (Colch) 2000. Dubrulle F. Travaglini P. In: Faucer BC. Sauerbrei EE. 37. Polycystic ovaries: implications of diagnosis with MR imaging. 4:347–51. Sagle M. The role of color Doppler imaging in the diagnosis of polycystic ovary syndrome. Hum Reprod 1987. Robert Y. Archibald P. Farquhar CM. 23. Medical ultrasound—germination and growth. The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women. Mason BA. Fertil Steril 1991. Vessey MP. Recurrent early miscarriage and polycystic ovaries. Jacobs HS. Balen AH. 12. Hypersecretion of luteinizing hormone—a significant cause of subfertility and miscarriage. Ridley N. 34. Bonney RC.2:15–32. 28. Battaglia C. Kingsland CR. J Endocrinol 1989. New York. 41. Thornton MH.):25. Lourusso R. Tucker M. Robert Y. Scaperrotta RC. Robert Y. Carmina E. 1999:1–17. Ultrasound diagnosis of polycystic ovary syndrome. infertility and miscarriage. Ultrasound assessment of ovarian stroma hypertrophy in hyperandrogenism and ovulation disorders: visual analysis versus computerized quantification. Takakura K. Arch Dis Child 1985. Kyei-Mensah A. 30. 39. Hum Reprod 1990. Polycystic ovaries and associated clinical and biochemical features in young women. Aust N Z J Obstet Gynaecol 1994. 36. Nicolson M. Eur J Ultrasound 1998. Artini PG. et al.10:249–62. 25. 14. 29. Ovarian volume and polycystic ovaries. 16. et al.98:661–5. Watson H. Allan PL. Mason HD.2:1375–9. Regan L. Hardiman P. Lakhani K.34:67–72. J Ultrasound Med 1985.7:S21–2. Regnani G. Farquhar CM. France JT. Nicolini U. et al. Wong L.9:219–22. Genazzani AD. Primavera MR. Ardaens Y.Review article: Polycystic ovaries 9. Bishop K. Lancet 1990. Hum Reprod 1997. Genazzani AR. Rushworth F. Ultrasound criteria in the diagnosis of polycystic ovary syndrome. The significance of polycystic-appearing ovaries versus normal-appearing ovaries in patients with polycystic ovary syndrome. Kimura I. Clin Endocrinol (Oxf) 1996. In: Baxter GM. 10. Tan SL. idiopathic precocious puberty and during low dose pulsatile gonadotrophin releasing hormone treatment of hypogonadotrophic hypogonadism. Macnamee MC.42:139–49. Baillieres Clin Endocrinol Metab 1996. et al. 15. Adv Exp Med Biol 1988. 19. Beard R. Cavender JL. Clinical diagnostic ultrasound (2nd edn).44:269–76. BMJ 1988.39:63–8. Orsini LF. Atiomo WU. Owen EJ. 17. Ardaens Y. Najmabadi S.60:116–9. Mitchell JM. Campbell S.64:307–12. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Abdulwahid N. Radiology 1996. J Clin Ultrasound 1981. Beard RW. Wilcox JG. Uterine size and endometrial thickness and the significance of cystic ovaries in women with pelvic pain due to congestion. 22. Polycystic ovary syndrome and cardiovascular disease. Murdoch WJ. Togashi K. Rai R. editor. 31. Adams J. 18. Dubbins P. 15 . Morley P. Constantinovici N. Ferrazzi E. Clin Endocrinol (Oxf) 1999. Pichinotta V. In: Kovacs GT. Acacio BD. Franks S. Jacobs HS. 35. 11. Fernando R.201:549–52. Fertil Steril 1995. Pearce S. Shaw S. Lemaitre L. Fleming JEE. Volpe A. Balen AH. Fox R. January 2002 26.123(Suppl. Pampiglione JS. 13.

Isaacs AJ. Internal carotid-artery response to 5% carbon dioxide in women with polycystic ovaries. Balint-Peric L. Jacobs HS. 54. 49.163:111–6. Yeh HC. Zaidi J. Gosling RG. Wood J. Radiology 1992. Carruth KB. Acta Obstet Gynecol Scand 1992. Baillieres Clin Endocrinol Metab 1996.43: 677–81. Purcell WM. 50. Beljic T.356:1166–7. Pache TD. Lo PTS.71:599–604. How to discriminate between normal and polycystic ovaries: transvaginal US study. 183:421–3. 16 The British Journal of Radiology. McKeigue P.):13. Mortality of women with polycystic ovary syndrome at long-term follow-up. Futterweit W. Polycystic ovarian disease: US features in 104 patients. 44. Janson PO. 1:175–9. Clin Endocrinol (Oxf) 1995.61:946–51. Dahlgren E. Constantinovici N. 45.10:311–8. J Clin Endocrinol Metab 1985. J Endocrinol 1996. Okolo S. 52. Lapidus L. Bettridge DJ. Jurkovic D.51:581–6. W U Atiomo and P Hardiman 43. Taylor MG. Coulson PB. Fauser BC. Conway GS. 53. Hop WC. Ultrasound Obstet Gynecol 1998. Fernando R. Unexpected effect of a nitric oxide donor on uterine artery Doppler velocimetry in oligomenorrheic women with polycystic ovaries. Prelevic GM. Ranney GB. Ultrasound Obstet Gynaecol 1991. Lees C. Interpretation of pulsatility index in feeder arteries to low-impedance vascular beds. January 2002 . Risk factors for coronary artery disease in lean and obese women with polycystic ovary syndrome. McKeigue PM.K Lakhani. 51. Cardiac flow velocity in women with the polycystic ovary syndrome. Prelevic GM. J Clin Epidemiol 1998. Hardiman P. Ginsburg J. Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. Lancet 2000. Jacobs HS. Radiology 1987. A M Seifalian. 48. Oden A. Thornton JC. Pierpoint T. Campbell S. Peripheral blood flow in young women with polycystic ovary syndrome. Wladimiroff JW.2:129–32. Wild RA. Clin Endocrinol 1992. Wild SH. 47. 151(Suppl. 46. Agrawal R. Ginsburg J. Polycystic ovary syndrome and risk for myocardial infarction: evaluated from a risk factor model based on a prospective study of women. Lakhani K. Cardiovascular disease and diabetes in women with polycystic ovary syndrome. Painter PC. Johansson S.37:119–25.

Sign up to vote on this title
UsefulNot useful